A quarter of 2020 deaths of people with HIV in the UK due to COVID-19
Four in ten PrEP recipients stop taking it within six months, global meta-analysis reveals
How a national intervention in Botswana improved same-day ART initiation for people newly diagnosed with HIV
17 months average wait to switch from a failing HIV treatment regimen in African countries
Medical mistrust is linked to discrimination, poor care engagement, and low adherence among Black adults in the US
Study shows Biktarvy for PEP has fewer side effects and better completion rates
Better adherence to PrEP is associated with more bone loss
Injectable cabotegravir plus rilpivirine every two months maintains viral suppression for three years, but carries higher risk of treatment failure
Top 5 HIV treatment stories from CROI 2022
